NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients

• Unité de recherche: INNOSUISSE
• Numéro de projet: 136.004 IP-LS
• Titre du projet anglais: NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

NanoZymeX develops lipid nanoparticle?based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients.